Skip to main content
Erschienen in: neurogenetics 2/2005

01.05.2005 | Short Communication

A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia

verfasst von: Johanna A. Reed, Phillip A. Wilkinson, Heema Patel, Michael A. Simpson, Arnaud Chatonnet, Dimitri Robay, Michael A. Patton, Andrew H. Crosby, Thomas T. Warner

Erschienen in: Neurogenetics | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

The hereditary spastic paraplegias (HSPs) are a clinically and genetically heterogeneous group of neurodegenerative disorders characterised by lower limb spasticity and weakness. Mutations in NIPA1 (Nonimprinted in Prader-Willi/Angelman syndrome 1) have recently been identified as a cause of autosomal dominant pure HSP, with one mutation described in two unrelated families. NIPA1 has no known function but is predicted to possess nine transmembrane domains and may function as a receptor or transporter. Here we present a large British pedigree in which linkage analysis conclusively demonstrates linkage to the NIPA1 locus (maximum multipoint LOD score 4.6). Subsequent mutation analysis identified a novel missense substitution in a highly conserved NIPA1 residue (G106R) which further confirms a causative link between NIPA1 mutation and autosomal dominant hereditary spastic paraplegia.
Literatur
1.
Zurück zum Zitat Fink JK (2002) Hereditary spastic paraplegia. Neurol Clin 20:711–726 Fink JK (2002) Hereditary spastic paraplegia. Neurol Clin 20:711–726
2.
Zurück zum Zitat Crosby AH, Proukakis C (2002) Is the transportation highway the right road for hereditary spastic paraplegia? Am J Hum Genet 71:1009–1016CrossRefPubMed Crosby AH, Proukakis C (2002) Is the transportation highway the right road for hereditary spastic paraplegia? Am J Hum Genet 71:1009–1016CrossRefPubMed
3.
Zurück zum Zitat Reid E (2003) Many pathways lead to hereditary spastic paraplegia. Lancet Neurol 2:210 Reid E (2003) Many pathways lead to hereditary spastic paraplegia. Lancet Neurol 2:210
4.
Zurück zum Zitat Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F et al (1999) Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23:296–303CrossRefPubMed Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F et al (1999) Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23:296–303CrossRefPubMed
5.
Zurück zum Zitat Errico A, Claudiani P, D’Addio M, Rugarli EI (2004) Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody, and the distal axon. Hum Mol Genet 13:2121–2132 Errico A, Claudiani P, D’Addio M, Rugarli EI (2004) Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody, and the distal axon. Hum Mol Genet 13:2121–2132
6.
Zurück zum Zitat Reid E, Connell J, Edwards TL, Duley S, Brown SE, Sanderson CM (2004) The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum Mol Genet 14:19–38 Reid E, Connell J, Edwards TL, Duley S, Brown SE, Sanderson CM (2004) The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum Mol Genet 14:19–38
7.
Zurück zum Zitat Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK (2003) NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73(4):967–971 Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK (2003) NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73(4):967–971
8.
Zurück zum Zitat Chai JH, Locke DP, Greally JM, Knoll JH, Ohta T, Dunai J et al (2003) Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 73:898–925 Chai JH, Locke DP, Greally JM, Knoll JH, Ohta T, Dunai J et al (2003) Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 73:898–925
9.
Zurück zum Zitat Fink JK, Heiman-Patterson T, Bird T, Cambi F, Dube MP, Figlewicz DA et al (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary spastic paraplegia working group. Neurology 46:1507–1514 Fink JK, Heiman-Patterson T, Bird T, Cambi F, Dube MP, Figlewicz DA et al (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary spastic paraplegia working group. Neurology 46:1507–1514
10.
Zurück zum Zitat Patel H, Hart PE, Warner T, Allen I, Phillimore HE, Silver JR et al (2001) Silver syndrome is not linked to any of the previously established autosomal dominant hereditary spastic paraplegia loci. Am J Med Genet 102:68–72 Patel H, Hart PE, Warner T, Allen I, Phillimore HE, Silver JR et al (2001) Silver syndrome is not linked to any of the previously established autosomal dominant hereditary spastic paraplegia loci. Am J Med Genet 102:68–72
11.
Zurück zum Zitat Lathrop G, Lalouel J, Julier C (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443–3446 Lathrop G, Lalouel J, Julier C (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443–3446
12.
Zurück zum Zitat Lathrop GM, Lalouel JM, Julier C, Ott J (1985) Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet 37:482–498PubMed Lathrop GM, Lalouel JM, Julier C, Ott J (1985) Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet 37:482–498PubMed
13.
Zurück zum Zitat Sobel E, Lange K (1996) Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58:1323–1337 Sobel E, Lange K (1996) Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58:1323–1337
14.
Zurück zum Zitat MEGA2 Version 3.0. (2002) University of Pittsburgh MEGA2 Version 3.0. (2002) University of Pittsburgh
15.
Zurück zum Zitat Corpet F (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16:10881–10890PubMed Corpet F (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16:10881–10890PubMed
16.
Zurück zum Zitat Fink JK, Sharp GB, Lange BM, Wu CB, Haley T, Otterud B et al (1995) Autosomal dominant, familial spastic paraplegia, type I: clinical and genetic analysis of a large North American family. Neurology 45:325–331 Fink JK, Sharp GB, Lange BM, Wu CB, Haley T, Otterud B et al (1995) Autosomal dominant, familial spastic paraplegia, type I: clinical and genetic analysis of a large North American family. Neurology 45:325–331
17.
Zurück zum Zitat Fink JK, Rainier S (2004) Hereditary spastic paraplegia: spastin phenotype and function. Arch Neurol 61:830–833 Fink JK, Rainier S (2004) Hereditary spastic paraplegia: spastin phenotype and function. Arch Neurol 61:830–833
18.
Zurück zum Zitat Heinzlef O, Paternotte C, Mahieux F, Prud’homme JF, Dien J, Madigand M et al (1998) Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet 35:89–93 Heinzlef O, Paternotte C, Mahieux F, Prud’homme JF, Dien J, Madigand M et al (1998) Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet 35:89–93
19.
Zurück zum Zitat Moller S, Croning MD, Apweiler R (2001) Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17:646–653 Moller S, Croning MD, Apweiler R (2001) Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17:646–653
20.
Zurück zum Zitat Lefevre C, Bouadjar B, Karaduman A, Jobard F, Saker S, Ozguc M et al (2004) Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis. Hum Mol Genet 13:2482–2473 Lefevre C, Bouadjar B, Karaduman A, Jobard F, Saker S, Ozguc M et al (2004) Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis. Hum Mol Genet 13:2482–2473
21.
Zurück zum Zitat Piomelli D (1991) Metabolism of arachidonic acid in nervous system of marine mollusk Aplysia californica. Am J Physiol 260:R844–R848 Piomelli D (1991) Metabolism of arachidonic acid in nervous system of marine mollusk Aplysia californica. Am J Physiol 260:R844–R848
22.
Zurück zum Zitat Schoneberg T, Schultz G, Gudermann T (1999) Structural basis of G protein-coupled receptor function. Mol Cell Endocrinol 151:181–193 Schoneberg T, Schultz G, Gudermann T (1999) Structural basis of G protein-coupled receptor function. Mol Cell Endocrinol 151:181–193
23.
Zurück zum Zitat Sugasawa T, Lenzen G, Simon S, Hidaka J, Cahen A, Guillaume JL et al (2001) The iodocyanopindolol and SM-11044 binding protein belongs to the TM9SF multispanning membrane protein superfamily. Gene 273:227–237 Sugasawa T, Lenzen G, Simon S, Hidaka J, Cahen A, Guillaume JL et al (2001) The iodocyanopindolol and SM-11044 binding protein belongs to the TM9SF multispanning membrane protein superfamily. Gene 273:227–237
24.
Zurück zum Zitat Schimmoller F, Diaz E, Muhlbauer B, Pfeffer SR (1998) Characterization of a 76 kDa endosomal, multispanning membrane protein that is highly conserved throughout evolution. Gene 216:311–318 Schimmoller F, Diaz E, Muhlbauer B, Pfeffer SR (1998) Characterization of a 76 kDa endosomal, multispanning membrane protein that is highly conserved throughout evolution. Gene 216:311–318
25.
Zurück zum Zitat Crosby AH (2003) Disruption of cellular transport: a common cause of neurodegeneration? Lancet Neurol 2:311–316 Crosby AH (2003) Disruption of cellular transport: a common cause of neurodegeneration? Lancet Neurol 2:311–316
Metadaten
Titel
A novel NIPA1 mutation associated with a pure form of autosomal dominant hereditary spastic paraplegia
verfasst von
Johanna A. Reed
Phillip A. Wilkinson
Heema Patel
Michael A. Simpson
Arnaud Chatonnet
Dimitri Robay
Michael A. Patton
Andrew H. Crosby
Thomas T. Warner
Publikationsdatum
01.05.2005
Erschienen in
Neurogenetics / Ausgabe 2/2005
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-004-0209-9

Weitere Artikel der Ausgabe 2/2005

neurogenetics 2/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.